TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
WGS

GeneDx Holdings Corp.

Healthcare · Diagnostics & Research

97.80$ -3.2% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement WGS
Line item 2019 2020 2021 2022 2023 2024 2025
-8.6% +18.3% +10.6% -13.7% +50.8% +40.0%
+54.6% +30.5% +14.3% -56.9% -1.3% +16.5%
-95.1% -512.4% +116.0% +53.4%
+108.2% +44.7% -18.0% -32.4% -21.5% +57.5%
+241.7% +104.5% +4.9% -38.1% -24.4% +49.2%
+117.3% +74.6% +49.2% -57.8% -19.6% +43.0%
+216.0% +14.6% +13.1% -16.3%
+296.0% +323.3% -327.4%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?